• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Wheels Up Announces Gregory Summe to Join Board of Directors

    8/8/24 8:05:00 AM ET
    $AVTR
    $GRAL
    $NXPI
    $STT
    Biotechnology: Laboratory Analytical Instruments
    Industrials
    Medical Specialities
    Health Care
    Get the next $AVTR alert in real time by email

    Veteran Leader Brings Deep Strategic, Aviation, and Governance Experience to Boardroom

    ATLANTA, Aug. 8, 2024 /PRNewswire/ -- Wheels Up Experience Inc. (NYSE:UP) today announced that Gregory L. Summe, Managing Partner of Glen Capital Partners LLC, joined its Board of Directors, effective August 7.

    Wheels Up (PRNewsfoto/Wheels Up)

    Summe fills the unexpired term of David Adelman, who is stepping down to focus on other professional pursuits. Summe's initial term as a Class II director will continue until the 2026 annual meeting of the Company's stockholders. He will serve on the Audit and Compensation Committees of the Board.

    "We are excited to welcome Greg Summe to our Board of Directors. He brings sharp strategic focus, decades of relevant experience, a successful track record as a public company CEO, and valuable insights as an investor and highly experienced corporate director," said Adam Zirkin, Chairman of the Board. "I would also like to thank David Adelman for his years of invaluable service and unwavering dedication to the Wheels Up mission."

    Summe currently serves as the Managing Partner of Glen Capital, a role which he has held since 2013. Previously, Summe was the Managing Director and Vice Chair of Global Buyout at The Carlyle Group ("Carlyle"), a leading global private equity firm, from 2009 to 2014. At Carlyle, he was a member of the firm's Operating Committee and responsible for the Buyout Funds in Financial Services, Infrastructure, Japan, the Middle East and Africa. Prior to joining Carlyle, he was the Chair and Chief Executive Officer of PerkinElmer Inc. ("PerkinElmer"), a global leader in health sciences, from 1998 to 2009. He also served as a senior advisor to Goldman Sachs Capital Partners, from 2008 to 2009. Prior to joining PerkinElmer, Summe held various leadership roles, including as President of General Aviation Avionics, President of the Aerospace Engines Group and President of the Automotive Products Group of AlliedSignal, now Honeywell International, General Manager of Commercial Motors at General Electric Company, and Partner with the global consulting firm McKinsey & Company, Inc.

    Summe is a deeply experienced corporate director, having served on 11 public boards over the span of his 23 years as a corporate director, including in board and committee leadership roles, and has served on the Board of Directors of State Street Corporation (NYSE:STT) since 2001, NXP Semiconductors NV (NASDAQ:NXPI) since 2015, Avantor Inc. (NYSE:AVTR) since 2020, and Grail, Inc. (NASDAQ:GRAL) since 2024.

    Summe received his Bachelor of Science and Master of Science degree in Electrical Engineering from the University of Kentucky and the University of Cincinnati, respectively, and a Master of Business Administration with distinction from the Wharton School at the University of Pennsylvania. He is also in the University of Kentucky's Hall of Distinction.

    About Wheels Up

    Wheels Up is a leading provider of on-demand private aviation and one of the largest companies in the industry. Wheels Up offers a complete global aviation solution with a large and diverse fleet and a global network of safety-vetted charter operators, all backed by an uncompromising commitment to safety and service. Customers can access charter and membership programs, as well as unique commercial travel benefits through a one-of-a-kind, strategic partnership with Delta Air Lines. Wheels Up also offers cargo, safety and security solutions and managed services to individuals, industry, government and civil organizations.

    Wheels Up is guided by the mission to deliver a premium solution for every customer journey. With the Wheels Up mobile app and website, members and customers have the digital convenience to search, book and fly.

    For more information, please visit: wheelsup.com

    Media Contact

    press@wheelsup.com

    Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/wheels-up-announces-gregory-summe-to-join-board-of-directors-302217239.html

    SOURCE Wheels Up

    Get the next $AVTR alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AVTR
    $GRAL
    $NXPI
    $STT

    CompanyDatePrice TargetRatingAnalyst
    State Street Corporation
    $STT
    4/6/2026$143.00Underperform → Neutral
    BofA Securities
    GRAIL Inc.
    $GRAL
    3/18/2026$65.00Hold → Buy
    TD Cowen
    Avantor Inc.
    $AVTR
    3/6/2026$8.50Equal Weight → Underweight
    Barclays
    State Street Corporation
    $STT
    2/23/2026$150.00Buy
    Citigroup
    GRAIL Inc.
    $GRAL
    2/19/2026$114.00Hold
    TD Cowen
    GRAIL Inc.
    $GRAL
    2/17/2026$113.00Outperform
    Robert W. Baird
    State Street Corporation
    $STT
    1/7/2026$138.00Buy → Hold
    Truist
    State Street Corporation
    $STT
    1/5/2026$152.00Overweight → Equal Weight
    Barclays
    More analyst ratings

    $AVTR
    $GRAL
    $NXPI
    $STT
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    State Street upgraded by BofA Securities with a new price target

    BofA Securities upgraded State Street from Underperform to Neutral and set a new price target of $143.00

    4/6/26 8:39:00 AM ET
    $STT
    Major Banks
    Finance

    GRAIL upgraded by TD Cowen with a new price target

    TD Cowen upgraded GRAIL from Hold to Buy and set a new price target of $65.00

    3/18/26 8:18:48 AM ET
    $GRAL
    Medical Specialities
    Health Care

    Avantor downgraded by Barclays with a new price target

    Barclays downgraded Avantor from Equal Weight to Underweight and set a new price target of $8.50

    3/6/26 8:24:43 AM ET
    $AVTR
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    $AVTR
    $GRAL
    $NXPI
    $STT
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Porter Brian J. bought $312,475 worth of shares (2,500 units at $124.99), increasing direct ownership by 39% to 8,898 units (SEC Form 4)

    4 - STATE STREET CORP (0000093751) (Issuer)

    3/9/26 4:00:51 PM ET
    $STT
    Major Banks
    Finance

    Director Lucier Gregory T bought $458,000 worth of shares (50,000 units at $9.16) (SEC Form 4)

    4 - Avantor, Inc. (0001722482) (Issuer)

    2/23/26 8:53:53 PM ET
    $AVTR
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Director Summe Gregory L bought $940,000 worth of shares (100,000 units at $9.40) (SEC Form 4)

    4 - Avantor, Inc. (0001722482) (Issuer)

    2/12/26 5:24:47 PM ET
    $AVTR
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    $AVTR
    $GRAL
    $NXPI
    $STT
    SEC Filings

    View All

    SEC Form 144 filed by GRAIL Inc.

    144 - GRAIL, Inc. (0001699031) (Subject)

    4/6/26 7:47:58 PM ET
    $GRAL
    Medical Specialities
    Health Care

    Avantor Inc. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - Avantor, Inc. (0001722482) (Filer)

    4/1/26 8:06:37 AM ET
    $AVTR
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    State Street Corporation filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits

    8-K - STATE STREET CORP (0000093751) (Filer)

    3/31/26 4:10:10 PM ET
    $STT
    Major Banks
    Finance

    $AVTR
    $GRAL
    $NXPI
    $STT
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Eck Steven W

    4 - Avantor, Inc. (0001722482) (Issuer)

    4/6/26 5:09:30 PM ET
    $AVTR
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    SEC Form 4 filed by Gordon Susan M.

    4 - STATE STREET CORP (0000093751) (Issuer)

    3/23/26 4:06:31 PM ET
    $STT
    Major Banks
    Finance

    SEC Form 3 filed by new insider Gordon Susan M.

    3 - STATE STREET CORP (0000093751) (Issuer)

    3/23/26 4:05:46 PM ET
    $STT
    Major Banks
    Finance

    $AVTR
    $GRAL
    $NXPI
    $STT
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Avantor® to Report First Quarter 2026 Earnings on Wednesday, April 29, 2026

    RADNOR, Pa., April 3, 2026 /PRNewswire/ -- Avantor, Inc. (NYSE:AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, announced that it will release its first quarter 2026 financial results before the market opens on Wednesday, April 29, and will hold a conference call to discuss the results on the same day at 8:00 a.m. Eastern Daylight Time. To hear a live audio webcast of the session, visit Events & Presentations in the Investor section of Avantor's website, ir.avantorsciences.com. A repl

    4/3/26 8:05:00 AM ET
    $AVTR
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Cancer Is Striking Earlier -- Superpower and GRAIL Are Partnering to Expand Early Detection

    Partnership expands access to breakthrough blood-based cancer screening intoSuperpower's comprehensive health check and personalized plans.SAN FRANCISCO, April 1, 2026 /PRNewswire/ -- Superpower, the first all-in-one proactive health platform, announced a strategic partnership with GRAIL, Inc. (NASDAQ:GRAL) to bring members access to the Galleri® multi-cancer early detection (MCED) test. Timed with the start of National Cancer Prevention and Early Detection Month, the partnership reflects a shared belief that cancer detection must evolve to meet a changing reality — removing traditional barriers to advanced testing and putting earlier insight, data, and control directly in people's hands.

    4/1/26 1:09:00 PM ET
    $GRAL
    Medical Specialities
    Health Care

    Avantor® Announces CFO Transition

    RADNOR, Pa., April 1, 2026 /PRNewswire/ -- Avantor, Inc. (NYSE:AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, today announced that Executive Vice President and Chief Financial Officer (CFO), R. Brent Jones, will leave the Company on or before June 24, 2026. Avantor has initiated a search to identify the Company's next CFO. To ensure a smooth transition until a new CFO is appointed, Steve Eck, Senior Vice President and Chief Accounting Officer (CAO), will serve as interim CFO upon Mr

    4/1/26 8:00:00 AM ET
    $AVTR
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    $AVTR
    $GRAL
    $NXPI
    $STT
    Financials

    Live finance-specific insights

    View All

    Avantor® to Report First Quarter 2026 Earnings on Wednesday, April 29, 2026

    RADNOR, Pa., April 3, 2026 /PRNewswire/ -- Avantor, Inc. (NYSE:AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, announced that it will release its first quarter 2026 financial results before the market opens on Wednesday, April 29, and will hold a conference call to discuss the results on the same day at 8:00 a.m. Eastern Daylight Time. To hear a live audio webcast of the session, visit Events & Presentations in the Investor section of Avantor's website, ir.avantorsciences.com. A repl

    4/3/26 8:05:00 AM ET
    $AVTR
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    State Street Corporation (NYSE: STT) Announces Date for Release of First-Quarter 2026 Financial Results and Conference Call Webcast

    State Street Corporation (NYSE:STT) plans to announce its first-quarter 2026 financial results on Friday, April 17, 2026 at approximately 7:30 a.m. ET. A conference call to review the firm's financial results will be held at 11:00 a.m. ET. The conference call will be accessible via audio webcast on State Street's Investor Relations website, http://investors.statestreet.com, or by telephone at (+1) 805 309 0220 (Participant Passcode: 68683#). Materials will be available on the website prior to the call. For those unable to listen to the live webcast, a replay will be available on the website for approximately one month. About State Street Corporation State Street Corporation (NYSE:ST

    3/18/26 4:30:00 PM ET
    $STT
    Major Banks
    Finance

    NXP Semiconductors Announces Quarterly Dividend

    EINDHOVEN, The Netherlands, March 12, 2026 (GLOBE NEWSWIRE) -- As part of its ongoing capital return program, NXP Semiconductors N.V. (NASDAQ:NXPI) today announced that its board of directors has approved the payment of an interim dividend. The actions are based on the continued and significant strength of the NXP capital structure, and the board's confidence in the company's ability to drive long-term growth and strong cash flow. The board of directors has approved the payment of an interim dividend of $1.014 per ordinary share for the first quarter of 2026. The interim dividend will be paid in cash on April 9, 2026, to shareholders of record as of March 25, 2026. Taxation – Cash Divide

    3/12/26 8:00:00 AM ET
    $NXPI
    Semiconductors
    Technology

    $AVTR
    $GRAL
    $NXPI
    $STT
    Leadership Updates

    Live Leadership Updates

    View All

    GRAIL Announces Retirement of CEO Bob Ragusa and Appointment of Josh Ofman, MD, MSHS, as Successor

    MENLO PARK, Calif., March 12, 2026 /PRNewswire/ -- GRAIL, Inc. (NASDAQ:GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today announced that Bob Ragusa will retire as Chief Executive Officer, effective June 1, 2026. GRAIL's Board of Directors has appointed the Company's President, Josh Ofman, MD, MSHS, to serve as GRAIL's Chief Executive Officer upon Ragusa's retirement. In addition, Ofman has been appointed to GRAIL's Board of Directors, effective immediately. Ofman's appointment is the culmination of a long-term comprehensive succession planning process to ensure leadership continuity and strategic execution. Ragusa will remain on GRAIL's Board unti

    3/12/26 4:30:00 PM ET
    $GRAL
    Medical Specialities
    Health Care

    Avantor® Appoints Simon Dingemans to its Board of Directors

    RADNOR, Pa., Dec. 18, 2025 /PRNewswire/ -- Avantor, Inc. (NYSE:AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, today announced the appointment of Simon Dingemans to its Board of Directors, effective January 2, 2026. Mr. Dingemans is an accomplished executive with extensive global leadership experience across healthcare, finance and strategic business transformation. He was previously the Chief Financial Officer of GlaxoSmithKline plc, a Partner at Goldman Sachs, and a Managing Dire

    12/18/25 8:05:00 AM ET
    $AVTR
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Avantor® Appoints Sanjeev Mehra to its Board of Directors

    RADNOR, Pa., Dec. 4, 2025 /PRNewswire/ -- Avantor, Inc. (NYSE:AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, today announced the appointment of Sanjeev Mehra to its Board of Directors, effective immediately.   Mr. Mehra is Co-Founder and serves as Managing Partner of Periphas Capital LP, a private equity firm focused on investing in technology enabled businesses in services, consumer and industrial end markets. Prior to founding Periphas, Mr. Mehra spent over 30 years at Goldman,

    12/4/25 4:15:00 PM ET
    $AVTR
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    $AVTR
    $GRAL
    $NXPI
    $STT
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Wheels Up Experience Inc.

    SC 13D/A - Wheels Up Experience Inc. (0001819516) (Subject)

    11/14/24 4:30:05 PM ET
    $UP
    Transportation Services
    Consumer Discretionary

    SEC Form SC 13G filed by GRAIL Inc.

    SC 13G - GRAIL, Inc. (0001699031) (Subject)

    11/14/24 3:35:14 PM ET
    $GRAL
    Medical Specialities
    Health Care

    Amendment: SEC Form SC 13G/A filed by Avantor Inc.

    SC 13G/A - Avantor, Inc. (0001722482) (Subject)

    11/14/24 1:28:33 PM ET
    $AVTR
    Biotechnology: Laboratory Analytical Instruments
    Industrials